Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Stock
NASDAQ · MIRM
91.83
Fundamentals
Market cap
$5.96B
Price / Earnings ratio
-7.5x
Price / Sales ratio
10.4x
Price / Book ratio
-615.7x
Return on assets
-1.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Mirum Pharmaceuticals, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees433
CEOMr. Christopher Peetz
IPO DateJul 18, 2019
HeadquartersFoster City, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Christopher Peetz | CEO & Director | 1979 |
| Mr. Peter Radovich M.B.A., Ph.D. | COO & President | 1978 |
| Mr. Eric H. Bjerkholt M.B.A., M.S. | Chief Financial Officer | 1960 |
| Dr. Joanne M. J. Quan M.D. | Chief Medical Officer | 1964 |
| Dr. Jean-Luc Girardet Ph.D. | Chief Technical Officer | — |
| Mr. Andrew McKibben | Senior Vice President, Strategic Finance & Investor Relations | — |
| Mr. Douglas T. Sheehy J.D. | Chief Legal Officer & Secretary | 1967 |
| Meredith Kiernan | Senior Director of Global Corporate Communications | — |
| Ms. Erin Campany | Chief People Officer | 1968 |
| Ms. Lara Longpre MBA, MSC | Chief Development Officer | 1970 |
Fundamentals
Valuation
Market cap$5.96B
Price-to-sales ratio10.38
Price-to-book value-615.68
Price-earnings ratio-7.50
Return on Equity-289.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-14.55
Income Statement
Average volume548,660
EBITDA$-756.09M
1 year high (52w)$130.00
1 year low (52w)$63.23
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



